Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06459310
PHASE2

Pilot Study on Evaluating the Geroprotective Effect of Metformin

Sponsor: Xuanwu Hospital, Beijing

View on ClinicalTrials.gov

Summary

The objective of this research is to assess the efficacy of oral metformin in mitigating the aging process in middle-aged and elderly males, to pinpoint sensitive indicators of human senescence, and to offer innovative frameworks and scientific insights for pharmaceutical interventions in aging.

Official title: A Phase II Exploratory Clinical Study Investigating the Geroprotective Effect of Metformin in Middle-aged and Elderly People

Key Details

Gender

MALE

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

130

Start Date

2024-06-30

Completion Date

2028-07-31

Last Updated

2025-03-21

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Metformin Hydrochloride tablet

Extended release oral tablets, 1000 mg/day, single dose

DRUG

Placebo

Oral tablets, 1000 mg/day, single dose

Locations (1)

Xuanwu Hospital Capital Medical University

Beijing, China